Iterum Therapeutics Plc (ITRM)


Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Iterum Therapeutics Plc chart...

About the Company

iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. for more information on iterum therapeutics please visit www.iterumtx.com.

Exchange

NASDAQ

$17M

Total Revenue

23

Employees

$0M

Market Capitalization

-0.45

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ITRM News

Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up

11d ago, source: Zacks.com on MSN

Iterum Therapeutics ITRM jumped 17.8% on Mar 6, 2024, and continued to gain another 3.4% in the after-market hours as it ...

Iterum Therapeutics Provides Business Update

12d ago, source:

Resubmission of NDA is On Track for First Half of Q2 24Extended Cash Runway into 2025DUBLIN, Ireland and CHICAGO, March 06, 2024 (GLOBE ...

Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat

3d ago, source: Yahoo Finance

DUBLIN, Ireland and CHICAGO, March 15, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next-generation oral ...

Rahul Jain and Gunjan Arora’s ‘Iterum’ on display at Art Centrix Space

6d ago, source: Indulgexpress on MSN

Art lovers can head over to Iterum, an art exhibition at Art Centrix Space, New Delhi. The exhibition is the outome of a ...

REFILE-Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows

11d ago, source:

AstraZeneca and Sanofi's antibody therapy was 90% effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV), a study by the U.S. Centers of Disease ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...